Cairo university
Giza, Manial, Egypt
NCT Number: NCT05289791
The aim of this study is to clinically compare post-operative pain levels after ultrasonic activation of Ceraseal bioceramic sealer versus non-activated bioceramic sealer for patients with symptomatic irreversible pulpitis related to mandibular premolar teeth.
Looking for future studies?
Notify Me18 year–50 year
All sexes
Interventional
Not applicable
Giza, Manial, Egypt
To clinically compare post-operative pain levels after ultrasonic activation of Ceraseal bioceramic sealer versus non-activated bioceramic sealer for patients with symptomatic irreversible pulpitis related to mandibular premolar teeth.Ultrasonic activation of Ceraseal bioceramic sealer for 20 seconds using non cutting ultrasonic tip.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
activation of bioceramic sealer using ultrasonic tip for 20 seconds in buccolingual and mesiodistal direction
Time frame: 6 hours
intensity of pain on modified Visual analogue scale
Time frame: 12 hours
intensity of pain on modified Visual analogue scale
Time frame: 24 hours
intensity of pain on modified Visual analogue scale
Time frame: 48 hours
intensity of pain on modified Visual analogue scale
Time frame: up to 48 hours postoperatively
number of analgesics taken by patient in 1st 48 hours
Time frame: Immediately after obturation.
presence or absence of sealer extrusion
Cairo University
Other
The Effect of Ultrasonic Activation of Bioceramic Sealer on Postoperative Pain in Teeth With Symptomatic Irreversible Pulpitis: A Randomized Clinical Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07290049
Neurologic Manifestations, Pain
Fujairah, Emirate of Fujairah, United Arab Emirates
View Trial DetailsNCT06298383
Symptomatic Irreversible Pulpitis
Cairo, Cairo Governorate, Egypt
View Trial DetailsNCT05982392
Neurologic Manifestations, Pain
Karachi, Sindh, Pakistan
View Trial DetailsNCT07510490
Neurologic Manifestations, Pain
Rawalpindi, Punjab Province, Pakistan
View Trial Details